Spinal mechanisms and feasibility of Dry Needling versus Botulinum Toxin Type A in poststroke lower limb spasticity: A proof-of-concept randomized clinical trial protocol (STROKE-POC)
Stroke often causes spasticity, impacting mobility and quality of life. Botulinum Toxin type A and Dry Needling are treatments that reduce spasticity, although Botulinum Toxin type A injections can cause adverse effects. No studies have directly compared their effects at spinal, muscular, functional...
| Autores: | , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2026 |
| País: | España |
| Institución: | Universidad Europea (UEM) |
| Repositorio: | ABACUS. Repositorio de Producción Científica |
| Idioma: | inglés |
| OAI Identifier: | oai:dnet:abacusreposi::b93f4a847579ce7e97b0556c60d4e2f3 |
| Acceso en línea: | https://hdl.handle.net/11268/17116 |
| Access Level: | acceso abierto |
| Palabra clave: | Fisioterapia Punción seca Toxinas botulínicas tipo A Espasticidad muscular Neurology Medicina preventiva Investigación médica Goal 3: Ensure healthy lives and promote well-being for all at all ages |
| Sumario: | Stroke often causes spasticity, impacting mobility and quality of life. Botulinum Toxin type A and Dry Needling are treatments that reduce spasticity, although Botulinum Toxin type A injections can cause adverse effects. No studies have directly compared their effects at spinal, muscular, functional, quality-of-life, and cost-effectiveness levels. This study aims to determine the spinal mechanisms of BTX-A and DN on post-stroke lower limb spasticity, while also assessing feasibility, safety, and exploratory effects at muscular, functional, quality-of-life, and cost-effectiveness levels. |
|---|